Incyte Corporation vs Union Pacific Corporation — how do they compare? Incyte Corporation trades at $115.7 (market cap $23.11B), while Union Pacific Corporation trades at $295.68 (market cap $175.89B). The key difference: Union Pacific Corporation is far larger — about 7.6× Incyte Corporation's market cap, and Union Pacific Corporation pays a 1.86% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.
| INCY | UNP | |
|---|---|---|
Market Cap | $23.11B | $175.89B |
Sector | Health | Industrials |
52-Week High | $118.52 | $301.75 |
52-Week Low | $67.38 | $214.91 |
Enterprise Value | $19.13B | $206.36B |
Dividend Yield | — | 1.86% |
Trailing returns across standard periods
Latest headlines on both assets
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the U.S., UP generated roughly $22 billion of revenue in 2021 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, and automotive goods. UP owns about one fourth of Mexican railroad Ferromex and derives about 10% of its revenue hauling freight to and from Mexico.
Read more on UNP →